Product Program year 2025 Source: CMS Open Payments

Cervidil

Drug Womens Health

NDC 55566-2800-1

Open in the dashboard

General payments

$24,348

601 payments

Research payments

$7,499

1 payment

Through program year 2025, $24,348 in general payments and $7,499 in research payments were reported against Cervidil (Womens Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $382 5
2024 General $1,243 16
2023 General $785 10
2022 General $575 11
2021 General $98 5
2020 General $1,697 49
2019 General $19,568 505
2019 Research $7,499 1

Breakdown

Who paid General payments · program years 2019–2025
  1. Ferring Pharmaceuticals Inc. $24,250 596 payments
  2. Ferring International Pharmascience Center US $98 5 payments
Top recipients General payments · program year 2025
  1. Christian Hobbs Nurse Practitioner, Family · Dallas, TX $76 20% · 1 payment
  2. Melissa Allred Advanced Practice Midwife · Wright-Patterson Afb, OH $76 20% · 1 payment
  3. Alanda James Nurse Practitioner · Ridgeland, MS $76 20% · 1 payment
  4. Geraldine Maurer Nurse Practitioner, Family · Pittsburgh, PA $76 20% · 1 payment
  5. Kristen Montgomery Toccoa, GA $76 20% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Nurse Practitioner, Family Nurse Practitioner $153 50% · 2 practitioners
  2. Nurse Practitioner $76 25% · 1 practitioner
  3. Advanced Practice Midwife $76 25% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Georgia $76 20% · 1 recipient
  2. Mississippi $76 20% · 1 recipient
  3. Ohio $76 20% · 1 recipient
  4. Pennsylvania $76 20% · 1 recipient
  5. Texas $76 20% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

601 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record